PBM Reform Bill Passes US Congress, But More Changes Likely Not Imminent

 
• By Cathy Kelly
  
Lawmakers enacted PBM reforms and reauthorized the pediatric rare disease priority review voucher after several unsuccessful attempts. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from PBMs

More from Market Access